Zoetis (ZTS) News
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
74.81+1.73 (+2.37%)
At close: Oct 9, 4:03 PM ET · Delayed 15 min
ZTS news summary
We found 4 recent headlines mentioning Zoetis (ZTS): 3 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, ZTS is up 2.37% at $74.81. The most recent story, "A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Zoetis headlines
- A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right NowKey PointsBoth stocks are home to niche-leading businesses.NasdaqZTS, BMI
- Daily Dividend Report: RPM,CSX,ZTS,EPD,NWNRPM International announced at its annual meeting of stockholders that its board of directors declared a regular quarterly cash dividend of $0.57 per share, payable on October 30, 2026, to…NasdaqRPM, CSX, ZTS, EPD
- Zoetis declares $0.53 dividendSeeking Alpha
- IDEXX Laboratories Vs. Zoetis: A Pre-Earnings ComparisonSeeking AlphaIDXX, ZTS